- Home
- MREO vs RBB Comparison
MREO vs RBB Comparison
Compare MREO & RBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- RBB
- Stock Information
- Founded
- MREO 2015
- RBB 2008
- Country
- MREO United Kingdom
- RBB United States
- Employees
- MREO N/A
- RBB N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- RBB Major Banks
- Sector
- MREO Health Care
- RBB Finance
- Exchange
- MREO Nasdaq
- RBB Nasdaq
- Market Cap
- MREO 281.6M
- RBB 335.4M
- IPO Year
- MREO N/A
- RBB 2017
- Fundamental
- Price
- MREO $1.76
- RBB $19.22
- Analyst Decision
- MREO Strong Buy
- RBB Hold
- Analyst Count
- MREO 5
- RBB 3
- Target Price
- MREO $7.40
- RBB $21.33
- AVG Volume (30 Days)
- MREO 932.9K
- RBB 41.2K
- Earning Date
- MREO 11-11-2025
- RBB 10-20-2025
- Dividend Yield
- MREO N/A
- RBB 3.33%
- EPS Growth
- MREO N/A
- RBB N/A
- EPS
- MREO N/A
- RBB 1.30
- Revenue
- MREO $500,000.00
- RBB $99,634,000.00
- Revenue This Year
- MREO N/A
- RBB $18.56
- Revenue Next Year
- MREO $55.50
- RBB $9.19
- P/E Ratio
- MREO N/A
- RBB $14.84
- Revenue Growth
- MREO N/A
- RBB N/A
- 52 Week Low
- MREO $1.47
- RBB $14.40
- 52 Week High
- MREO $4.72
- RBB $25.30
- Technical
- Relative Strength Index (RSI)
- MREO 48.66
- RBB 44.59
- Support Level
- MREO $1.68
- RBB $18.80
- Resistance Level
- MREO $1.88
- RBB $19.62
- Average True Range (ATR)
- MREO 0.07
- RBB 0.56
- MACD
- MREO 0.01
- RBB -0.16
- Stochastic Oscillator
- MREO 45.45
- RBB 35.00
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About RBB RBB Bancorp
RBB Bancorp operates as a bank holding company. It provides various banking products and services such as checking, savings, money market accounts, and certificates of deposits. Its Specific services include remote deposit, E-banking, mobile banking, commercial and investor real estate loans, business loans and lines of credit, Small Business Administration (SBA) 7A and 504 loans, mortgage loans, trade finance, and a full range of depository accounts. It generates its revenue from interest received on loans and leases and, to a lesser extent, from interest received on investment securities and derives income from noninterest sources, such as fees received in connection with various lending and deposit services, loan servicing, gain on sales of loans, and wealth management services.